Benign neoplasm: Ascending colon

CD2_BENIGN_ASCENDING_COLON

colonic neoplasm: A benign or malignant neoplasm that affects the colon. Representative examples of benign neoplasms include lipoma and leiomyoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. Colonic adenomas always exhibit epithelial dysplasia and are considered premalignant neoplasms.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D12.2& Hospital discharge: ICD-8 — 21133 Cause of death: ICD-10 — D12.2& Cause of death: ICD-8 — 21133 2 out of 7 registries used, show all original rules.	4885
4. Check minimum number of events None	4885
5. Include endpoints None	4885
6. Filter based on genotype QC (FinnGen only)	4885

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D12
Name in latin: Neoplasma benignum coli ascendentis

NAME	CD2_BENIGN_ASCENDING_COLON
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D122
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	21133
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D122
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	21133
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Ascending colon based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Ascending colon

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	22447	11115	11250
Only index persons	21432	10743	10689
Unadjusted period prevalence (%)
Whole population	0.32	0.32	0.31
Only index persons	0.40	0.39	0.41
Median age at first event (years)
Whole population	69.17	68.81	69.51
Only index persons	68.94	68.60	69.29

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4885	2403	2482
Unadjusted period prevalence (%)	0.96	0.82	1.09
Median age at first event (years)	68.42	67.09	69.72

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4204: Matched controls
42041

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

UJF30

NOMESCO Finland

Ileoscopy through colon

7.2

323.0

1151

2104

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

14.5

323.0

928

805

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

22.2

323.0

1527

1053

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

19.3

323.0

686

420

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

9.8

323.0

710

852

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

4.7

323.0

1696

5238

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

4503599627370496.0

323.0

4195

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

23.9

323.0

770

390

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

8.0

323.0

822

1234

UJF32

NOMESCO Finland

Coloscopy

13.6

323.0

3177

7772

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

19.2

320.7

504

296

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

19.1

285.8

449

261

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.3

275.0

1976

8805

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.3

107.2

615

2090

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

10.3

106.7

218

223

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

100.4

1329

7270

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

100.3

1612

9603

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

90.3

2185

15080

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

3.0

81.7

519

1872

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.6

76.8

647

2770

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

76.8

1080

5933

JFA42

NOMESCO Finland

Endoscopic injection in colon

26.5

75.9

106

A02BC02

ATC

pantoprazole; systemic

1.8

68.1

2857

22713

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

3.3

67.4

373

1214

WX002

NOMESCO Finland

Sedation and analgesia

2.0

66.7

1034

5855

N02BE01

ATC

paracetamol; systemic, rectal

2.2

66.3

3685

32225

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.4

64.0

592

2646

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.7

57.5

417

1620

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

8.2

56.1

129

162

K92.1

ICD-10 Finland

Melaena

3.1

56.1

337

1159

J01DB01

ATC

cefalexin; oral

1.8

53.8

3328

28532

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.5

52.7

449

1909

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

52.4

573

2764

P01AB01

ATC

metronidazole; oral, rectal

1.7

50.6

1584

11124

K63.5

ICD-10 Finland

Polyp of colon

6.1

49.2

138

231

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

11.6

49.2

UJH02

NOMESCO Finland

Anoscopy

3.3

48.5

264

845

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.9

48.2

307

1095

A02BC03

ATC

lansoprazole; oral

1.7

48.1

1339

9061

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

5.4

46.6

144

272

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

46.5

782

4486

JN4BD

NOMESCO Finland

Extensive body CT

2.1

45.5

597

3103

N02AX02

ATC

tramadol; systemic, rectal

1.6

45.1

1834

13685

B01AB05

ATC

enoxaparin; parenteral

1.7

44.9

1416

9876

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

15.3

44.5

A02BC05

ATC

esomeprazole; systemic

1.6

43.2

1718

12706

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

42.1

622

3384

R06.0

ICD-10 Finland

Dyspnoea

1.7

41.6

1126

7489

JFB30

NOMESCO Finland

Right hemicolectomy

5.3

40.9

129

250

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

4.0

39.1

162

415

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

37.7

670

3889

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

13.4

37.6

H02AB06

ATC

prednisolone; systemic

1.5

36.8

1940

15137

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

35.9

1138

7842

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

35.5

1199

8396

D01

ICPC

Abdominal pain/cramps general

2.1

35.3

422

2097

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

33.6

907

5966

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

33.6

397

1963

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

7.9

33.3

C03CA01

ATC

furosemide; systemic

1.5

32.3

1342

9828

C07AB07

ATC

bisoprolol; oral

1.5

32.3

2131

17258

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

6.4

32.1

137

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

3.5

31.8

157

467

N03AX16

ATC

pregabalin; oral

1.6

31.7

981

6677

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

31.6

1599

12226

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

3.7

31.4

142

394

D12.1

ICD-10 Finland

Benign neoplasm: Appendix

15.0

31.3

S18

ICPC

Laceration/cut

1.5

31.2

1784

13985

R4110

NOMESCO Finland

Physiotherapy

1.6

31.2

1115

7866

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

30.8

475

2607

R03AC02

ATC

salbutamol; inhalant

1.5

30.8

1964

15735

J01MA02

ATC

ciprofloxacin; systemic

1.5

30.5

1622

12505

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

29.8

1091

7726

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

29.5

729

4656

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

4.6

28.8

103

230

AA1AD

NOMESCO Finland

CT of head and brain

1.5

28.5

1061

7530

WX110

NOMESCO Finland

Local anesthesy

1.4

27.7

2548

21728

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

6.2

27.6

122

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

27.6

1415

10762

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

27.1

354

1820

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

27.1

2606

22370

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.0

26.7

158

535

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

26.4

1277

9570

A02BC01

ATC

omeprazole; systemic

1.5

26.3

1158

8508

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

26.2

905

6285

M79.6

ICD-10 Finland

Pain in limb

1.5

26.1

1390

10625

C10AA05

ATC

atorvastatin; oral

1.4

26.0

1733

13837

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

25.9

1401

10733

J01CA04

ATC

amoxicillin; systemic

1.5

25.9

3043

27012

UJF92

NOMESCO Finland

Capsular endoscopy

3.9

25.9

110

290

C05AA08

ATC

fluocortolone; rectal, topical

1.7

25.8

600

3755

J01AA02

ATC

doxycycline; systemic

1.5

25.8

3109

27723

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.7

25.7

186

719

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

25.3

1765

14185

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

7.7

25.2

K55.2

ICD-10 Finland

Angiodysplasia of colon

7.1

25.1

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

25.0

297

1468

XKD00

NOMESCO Finland

Uroflowmetry

1.6

24.9

775

5241

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

24.4

571

3574

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

24.2

690

4559

N06AX11

ATC

mirtazapine; oral

1.5

24.2

1186

8878

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.9

24.2

147

510

JN4AD

NOMESCO Finland

Body CT examination

1.9

24.1

368

2004

E0000UV

ATC

1.4

24.0

1441

11228

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

23.9

1052

7694

SPAT1263

SPAT

Sampling

1.4

23.9

1647

13164

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

23.9

711

4749

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

3.7

23.6

106

294

A02BA02

ATC

ranitidine; systemic

1.5

23.2

843

5905

R01AD09

ATC

mometasone; nasal

1.4

23.2

1544

12241

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

23.1

441

2596

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.3

23.1

229

1044

K29.7

ICD-10 Finland

Gastritis, unspecified

2.6

23.0

179

719

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

23.0

223

1005

A07EC02

ATC

mesalazine; oral, rectal

2.3

22.7

223

1010

ZX120

NOMESCO Finland

Intravenous

1.8

22.6

402

2312

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

22.5

700

4723

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

22.1

401

2318

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

22.0

630

4158

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.6

22.0

162

632

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

21.8

1054

7836

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

21.6

780

5446

B01AA03

ATC

warfarin; systemic

1.5

21.5

921

6676

A07EA06

ATC

budesonide; oral, local oral

2.8

21.4

140

510

K59.0

ICD-10 Finland

Constipation

2.1

21.3

257

1280

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

21.2

391

2271

G47.3

ICD-10 Finland

Sleep apnoea

1.5

21.1

807

5702

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.0

21.1

281

1451

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

4.2

21.1

196

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

21.0

1472

11718

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

20.9

1221

9407

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.1

20.8

246

1211

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

20.7

1139

8670

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

20.4

1642

13370

M54.5

ICD-10 Finland

Low back pain

1.4

20.3

1173

9009

L01BC06

ATC

capecitabine; oral

2.4

20.2

177

759

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

20.2

2467

21478

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

20.1

745

5225

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

20.1

1010

7549

K64.0

ICD-10 Finland

First degree haemorrhoids

3.9

19.9

212

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

19.9

771

5460

A98

ICPC

Health maint/preventive medicine

1.7

19.9

3847

36436

D11

ICPC

Diarrhoea

1.8

19.8

347

1984

R42

ICD-10 Finland

Dizziness and giddiness

1.5

19.5

883

6456

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

19.5

221

1071

D02

ICPC

Abdominal pain epigastric

2.1

19.4

216

1038

L03

ICPC

Low back symptom/complaint

1.5

19.4

877

6409

C08CA01

ATC

amlodipine; oral

1.4

19.3

1557

12647

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

19.3

205

963

R03BA02

ATC

budesonide; inhalant

1.5

19.2

632

4307

A06AC51

ATC

ispaghula, combinations; systemic

2.1

19.2

217

1051

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

19.1

405

2456

SPAT1104

SPAT

Monitoring of emergency patient

1.9

19.1

291

1583

J02AC01

ATC

fluconazole; systemic

1.4

19.0

1294

10209

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

6.5

19.0

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

18.9

682

4745

A06AD11

ATC

lactulose; oral

1.6

18.9

593

3991

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

18.9

1777

14773

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.4

18.9

159

667

S29

ICPC

Skin symptom/complaint other

1.5

18.7

664

4601

B01AB10

ATC

tinzaparin; parenteral

1.9

18.7

301

1670

D06

ICPC

Abdominal pain localized other

1.9

18.7

303

1686

N05CF01

ATC

zopiclone; oral

1.4

18.6

1264

9958

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

6.3

18.6

ZXA00

NOMESCO Finland

Right side

1.4

18.6

1135

8777

A11

ICPC

Chest pain NOS

1.8

18.5

324

1849

K30

ICD-10 Finland

Functional dyspepsia

1.7

18.5

389

2355

R53

ICD-10 Finland

Malaise and fatigue

1.5

18.4

761

5450

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

18.3

298

1662

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

18.2

365

2174

J45

ICD-10 Finland

Asthma

1.8

18.2

356

2104

C10AA01

ATC

simvastatin; oral

1.3

18.2

1970

16712

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

18.1

572

3859

J01MA12

ATC

levofloxacin; systemic

1.5

18.1

758

5446

A02BC04

ATC

rabeprazole; oral

1.8

18.0

316

1804

R06AE07

ATC

cetirizine; oral

1.4

17.9

1472

11954

R03AC03

ATC

terbutaline; inhalant

1.6

17.8

505

3314

SPAT1153

SPAT

Removal of sutures

1.4

17.8

1325

10585

UKC02

NOMESCO Finland

Cystoscopy

1.5

17.7

715

5091

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

17.7

460

2952

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

17.7

452

2888

R02

ICPC

Shortness of breath/dyspnoea

1.6

17.6

478

3105

A04

ICPC

Weakness/tiredness general

1.6

17.4

473

3073

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

5.2

17.3

102

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

17.3

282

1570

T90

ICPC

Diabetes non-insulin dependent

1.4

17.3

978

7439

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

17.3

593

4071

D16

ICPC

Rectal bleeding

2.9

17.2

106

374

M25.5

ICD-10 Finland

Pain in joint

1.4

17.1

977

7446

WX320

NOMESCO Finland

Spinalanesthesy

1.4

17.0

891

6679

R03DC03

ATC

montelukast; oral

1.6

17.0

533

3581

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

16.8

582

4006

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

16.7

571

3917

I84.5

ICD-10 Finland

External hemorrhoids without complication

2.5

16.7

136

561

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

16.7

646

4556

207

Kela drug reimbursment

Chronic arrhythmias

1.5

16.6

660

4680

D18

ICPC

Change in faeces/bowel movements

2.8

16.5

105

376

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.4

16.5

138

580

A10BH01

ATC

sitagliptin; oral

1.6

16.4

425

2719

A10BA02

ATC

metformin; oral

1.4

16.4

1159

9152

WX892

NOMESCO Finland

Monitored bed care

1.7

16.3

322

1908

ZXA05

NOMESCO Finland

Left side

1.4

16.3

1035

8024

R51.80

ICD-10 Finland

Headache

1.6

16.2

450

2935

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

5.0

16.2

102

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.3

16.2

253

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

15.4

16.2

H02AB04

ATC

methylprednisolone; systemic

1.5

16.1

553

3792

M03BX02

ATC

tizanidine; oral

1.3

16.1

2179

18949

SPAT1254

SPAT

Administration of medicine

1.5

16.1

568

3921

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.7

15.8

108

407

G04CA02

ATC

tamsulosin; oral

1.4

15.8

1003

7769

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

15.8

441

2881

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

15.7

273

1555

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

15.7

287

1660

J01FA06

ATC

roxithromycin; oral

1.3

15.7

1480

12199

A10AE04

ATC

insulin glargine; parenteral

1.7

15.7

367

2289

C09CA06

ATC

candesartan; oral

1.4

15.7

801

5968

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.2

15.6

157

722

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

15.5

383

2423

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

15.4

182

896

JFA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in colon

14.8

15.3

K02.1

ICD-10 Finland

Caries of dentine

1.3

15.2

1858

15880

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

5.3

15.1

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.8

15.1

281

1638

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

14.9

1789

15236

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

14.9

314

1898

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

14.9

304

1822

M04AA01

ATC

allopurinol; systemic

1.5

14.9

559

3909

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

14.8

1061

8373

K62.1

ICD-10 Finland

Rectal polyp

3.7

14.7

171

R35

ICD-10 Finland

Polyuria

1.8

14.5

269

1563

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

14.5

234

1298

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

14.5

1905

16407

A07AA02

ATC

nystatin; oral

1.8

14.5

265

1535

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

14.4

1137

9101

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

3.6

14.4

184

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

14.4

940

7295

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

14.4

186

954

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

14.4

2132

18652

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

14.3

952

7414

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.5

14.3

108

431

D64.8

ICD-10 Finland

Other specified anaemias

3.0

14.2

271

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

14.1

435

2907

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

14.1

251

1444

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

14.0

165

814

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.9

14.0

203

1086

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

14.0

608

4380

H02AB07

ATC

prednisone; oral

1.5

14.0

540

3798

J01DA01

ATC

[U] cefalexin; systemic

1.3

13.9

2304

20414

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

13.8

614

4439

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

13.8

754

5669

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

13.7

294

1784

R50.9

ICD-10 Finland

Fever, unspecified

1.5

13.7

475

3265

C03DA01

ATC

spironolactone; oral

1.5

13.7

430

2890

R03BB04

ATC

tiotropium bromide; inhalant

1.6

13.6

418

2791

I84

ICD-10 Finland

Hemorrhoids

2.3

13.6

120

522

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.5

13.5

107

438

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

5.0

13.5

Z71.8

ICD-10 Finland

Other specified counselling

1.4

13.5

774

5870

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

13.4

404

2685

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

10.1

13.4

SPAT1301

SPAT

No procedures

1.3

13.4

1235

10089

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

13.4

254

1490

Z01.2

ICD-10 Finland

Dental examination

1.3

13.4

1327

10960

N05CF02

ATC

zolpidem; oral

1.4

13.3

602

4365

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

13.3

1149

9300

R07.3

ICD-10 Finland

Other chest pain

1.6

13.3

360

2333

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.3

13.3

117

506

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.4

13.3

577

4156

G44.2

ICD-10 Finland

Tension-type headache

1.5

13.2

419

2817

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

13.2

257

1516

-60

ICPC

Result test/procedure

1.8

13.2

232

1327

C09CA01

ATC

losartan; oral

1.3

13.2

968

7646

D07AC01

ATC

betamethasone; topical

1.3

13.1

1252

10278

N06AB10

ATC

escitalopram; oral

1.5

13.1

552

3950

R01AD08

ATC

fluticasone; nasal

1.4

13.0

913

7156

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

2.5

13.0

100

403

N03AX12

ATC

gabapentin; oral

1.4

13.0

568

4095

A11CC03

ATC

alfacalcidol; systemic

2.5

12.9

103

423

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

12.9

1505

12687

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

12.9

581

4209

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

2.8

12.9

297

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

6.4

12.9

XF402

NOMESCO Finland

ECG with work load test

1.5

12.9

451

3103

N19

ICD-10 Finland

Unspecified kidney failure

2.1

12.9

145

703

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

12.8

1385

11554

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

12.8

898

7030

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

12.8

502

3536

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

12.8

248

1461

D12

ICPC

Constipation

2.1

12.8

145

708

UJG02

NOMESCO Finland

Proctoscopy

2.5

12.7

100

410

L01

ICPC

Neck symptom/complaint

1.5

12.7

449

3093

A01

ICPC

Pain general/multiple sites

1.7

12.6

282

1733

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.4

12.6

791

6087

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

3.7

12.6

148

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

12.5

846

6581

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

12.5

407

2754

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

12.5

271

1653

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

12.5

1212

9957

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

12.5

226

1307

R11

ICD-10 Finland

Nausea and vomiting

1.7

12.4

265

1610

K51.5

ICD-10 Finland

Left sided colitis

2.5

12.4

397

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.4

12.4

100

416

L04AX01

ATC

azathioprine; systemic

2.0

12.3

151

760

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

12.3

1181

9679

K57

ICD-10 Finland

Diverticular disease of intestine

2.5

12.3

380

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.9

12.3

260

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

12.3

363

2403

SPAT1262

SPAT

Handing over of treatment supplies

1.4

12.3

733

5587

M48.0

ICD-10 Finland

Spinal stenosis

1.5

12.2

511

3646

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.3

12.2

183

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.6

12.2

289

1810

K78

ICPC

Atrial fibrillation/flutter

1.6

12.1

346

2268

ICD-10 Finland

2.4

12.1

105

453

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

12.1

608

4494

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

12.1

1108

9022

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

3.7

12.1

143

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

12.1

830

6473

WX290

NOMESCO Finland

Other blockade of nerve

1.3

12.1

1260

10445

R05

ICD-10 Finland

Cough

1.4

12.0

692

5243

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.8

12.0

200

1128

XF404

NOMESCO Finland

Ambulatory ECG

1.5

12.0

371

2482

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

12.0

556

4051

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

6.2

11.9

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

11.9

176

950

R19.4

ICD-10 Finland

Change in bowel habit

2.4

11.8

100

427

A07EA02

ATC

hydrocortisone; rectal

2.5

11.8

355

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

11.8

492

3510

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.9

11.8

159

831

C10AX09

ATC

ezetimibe; oral

1.5

11.7

443

3094

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

11.7

440

3070

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

11.7

238

1426

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

11.6

364

2439

A10BB12

ATC

glimepiride; oral

1.6

11.6

305

1958

R15

ICD-10 Finland

Faecal incontinence

2.3

11.6

109

489

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

11.6

612

4564

JN4CD

NOMESCO Finland

Very extensive body CT

1.9

11.5

171

923

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

11.5

284

1796

J01FA10

ATC

azithromycin; systemic

1.3

11.5

1880

16462

A10AE05

ATC

insulin detemir; parenteral

1.8

11.5

201

1151

SPAT1285

SPAT

Provision of consultation response

1.8

11.4

213

1243

N05BA04

ATC

oxazepam; oral

1.3

11.4

853

6734

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

11.4

380

2587

A46

ICD-10 Finland

Erysipelas

1.4

11.3

541

3957

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.2

11.3

189

D75

ICPC

Malignant neoplasm colon/rectum

3.8

11.3

121

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

11.3

620

4656

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

11.3

605

4524

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

3.9

11.2

117

K50.0

ICD-10 Finland

Crohn disease of small intestine

3.2

11.2

174

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

11.2

577

4286

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.9

11.1

170

931

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

11.1

1411

11967

R60.0

ICD-10 Finland

Localized oedema

1.5

11.1

421

2947

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

11.0

485

3496

B82

ICPC

Anaemia other/unspecified

2.2

11.0

108

495

B01AF02

ATC

apixaban; oral

1.5

11.0

406

2821

L17

ICPC

Foot/toe symptom/complaint

1.3

11.0

912

7305

M01AH05

ATC

etoricoxib; oral

1.2

10.9

2047

18166

D02AE01

ATC

carbamide; topical

1.7

10.9

232

1411

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

10.8

348

2350

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

10.8

1292

10867

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

10.8

614

4637

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

10.8

849

6751

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.8

10.7

170

942

R13

ICD-10 Finland

Dysphagia

1.6

10.7

245

1522

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

10.7

218

1309

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

10.7

922

7427

D19

ICPC

Teeth/gum symptom/complaint

1.3

10.6

784

6168

SPAT1101

SPAT

Orthostatic test

1.8

10.6

193

1117

K62.7

ICD-10 Finland

Radiation proctitis

4.2

10.6

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

10.6

205

1210

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.7

10.6

239

1477

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

10.6

371

2554

E66.8

ICD-10 Finland

Other obesity

1.9

10.6

147

776

XJH00

NOMESCO Finland

Transanal ultrasonography

1.6

10.5

278

1790

A10BH05

ATC

linagliptin; oral

1.7

10.5

201

1183

JFB46

NOMESCO Finland

Resection of sigmoid colon

3.0

10.5

194

M01AX17

ATC

nimesulide; oral

1.3

10.5

939

7598

R03AC13

ATC

formoterol; inhalant

1.8

10.5

185

1063

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

7.3

10.4

SPAT1255

SPAT

Intravenous administration of medicine

1.6

10.4

247

1543

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

10.4

158

863

K22.1

ICD-10 Finland

Ulcer of oesophagus

2.4

10.4

351

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.4

10.4

460

3318

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

10.4

235

1451

TQW99

NOMESCO Finland

Other minor procedure on skin

1.7

10.4

196

1150

C08CA13

ATC

lercanidipine; oral

1.4

10.3

525

3890

D04

ICPC

Rectal/anal pain

3.0

10.3

201

R12

ICD-10 Finland

Heartburn

1.6

10.2

237

1472

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

10.2

822

6546

M01AE02

ATC

naproxen; oral, rectal

1.2

10.2

1943

17220

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

10.2

284

1853

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

10.1

154

843

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

10.1

495

3637

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

5.9

10.1

M54

ICD-10 Finland

Dorsalgia

1.5

10.1

342

2338

C10AC01

ATC

colestyramine; oral

2.2

10.1

102

477

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

10.0

1345

11449

R19.5

ICD-10 Finland

Other faecal abnormalities

2.8

10.0

218

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

10.0

251

1596

R63.4

ICD-10 Finland

Abnormal weight loss

1.9

10.0

139

737

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

10.0

389

2735

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

10.0

403

2856

B80

ICPC

Iron deficiency anaemia

2.6

10.0

284

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

10.0

797

6342

N01

ICPC

Headache

1.6

10.0

241

1519

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.6

9.9

264

1703

M02AA07

ATC

piroxicam; topical

1.3

9.9

1379

11785

J20

ICD-10 Finland

Acute bronchitis

1.5

9.9

318

2145

E000001

ATC

1.3

9.9

644

4970

-50

ICPC

Medication/prescr/renewal

1.8

9.8

161

904

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

9.8

488

3594

127

Kela drug reimbursment

Transplant complication

2.9

9.8

197

B01AB04

ATC

dalteparin; parenteral

1.7

9.8

189

1118

E22.0

ICD-10 Finland

Acromegaly and pituitary gigantism

10.6

9.8

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

9.8

328

2237

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

9.7

660

5121

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.0

9.7

126

651

R96

ICPC

Asthma

1.5

9.7

305

2050

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

9.7

1126

9414

KMAK

NOMESCO Finland

1.2

9.6

1647

14394

8211/2-C18.2

ICD-O-3

Tubular adenocarcinoma in situ of ascending colon

55.1

9.6

M01AC06

ATC

meloxicam; systemic, rectal

1.3

9.6

1320

11257

J01FF01

ATC

clindamycin; systemic

1.3

9.6

946

7745

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

9.5

2371

21564

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

9.5

427

3089

SPAT1312

SPAT

General health counselling

1.3

9.5

1104

9222

R03BA05

ATC

fluticasone; inhalant

1.4

9.5

578

4409

WX722

NOMESCO Finland

PEEP

1.7

9.4

179

1052

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

9.4

259

1685

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

9.4

130

689

130

Kela drug reimbursment

Malignant tumour

1.5

9.4

322

2205

A02BA04

ATC

nizatidine; systemic

1.5

9.4

291

1949

C08DA01

ATC

verapamil; systemic

1.8

9.3

158

895

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

4.2

9.3

K64.1

ICD-10 Finland

Second degree haemorrhoids

3.1

9.3

165

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.9

9.3

131

699

R74

ICPC

Upper respiratory infection acute

1.3

9.3

708

5587

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

3.7

9.3

102

J01FA09

ATC

clarithromycin; systemic

1.3

9.2

997

8256

I50.0

ICD-10 Finland

Congestive heart failure

1.5

9.1

281

1876

A12AA04

ATC

calcium carbonate; oral

2.5

9.1

278

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

7.7

9.1

SPAT1310

SPAT

Counselling related to known health issue

1.3

9.1

1151

9704

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.5

9.1

262

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.9

9.1

125

660

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.8

9.0

207

R4120

NOMESCO Finland

Occupational therapy

1.6

9.0

215

1351

K64.2

ICD-10 Finland

Third degree haemorrhoids

3.9

9.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

9.0

459

3397

Z01.7

ICD-10 Finland

Laboratory examination

1.4

8.9

366

2601

M79.1

ICD-10 Finland

Myalgia

1.4

8.9

385

2761

R51

ICD-10 Finland

Headache

1.8

8.9

136

746

TFP20

NOMESCO Finland

Cardiodefibrillation

1.5

8.9

305

2085

L57.0

ICD-10 Finland

Actinic keratosis

1.4

8.9

396

2858

N17

ICPC

Vertigo/dizziness

1.4

8.9

401

2900

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

8.9

209

1306

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

8.9

283

1908

S04

ICPC

Lump/swelling localized

1.5

8.9

293

1988

B01AF01

ATC

rivaroxaban; oral

1.4

8.9

476

3551

R06AX22

ATC

ebastine; oral

1.4

8.9

493

3703

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

8.9

899

7374

K85

ICPC

Elevated blood pressure

1.3

8.9

573

4411

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.2

8.8

410

J01MA14

ATC

moxifloxacin; systemic

1.5

8.8

314

2169

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

8.8

434

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

8.8

117

611

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

8.8

831

6753

D78

ICPC

Neoplasm digestive benign/unspecif

8.6

8.8

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.9

8.8

125

671

K80

ICPC

Cardiac arrhythmia NOS

1.5

8.8

268

1790

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

5.9

8.7

L60.0

ICD-10 Finland

Ingrowing nail

1.8

8.7

145

818

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

8.7

846

6904

SPAT1210

SPAT

Application of cast or individual aid

1.8

8.7

145

822

R03BA08

ATC

ciclesonide; inhalant

1.5

8.6

262

1749

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.0

8.6

105

532

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.8

8.6

152

877

L14

ICPC

Leg/thigh symptom/complaint

1.5

8.6

257

1706

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.6

8.6

227

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.4

8.5

388

2811

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

8.5

119

634

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

8.5

334

2350

A07AA09

ATC

vancomycin; oral

2.7

8.5

198

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.2

8.4

127

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.5

8.4

327

2298

S21

ICPC

Skin texture symptom/complaint

1.4

8.4

443

3298

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

8.4

307

2131

L04

ICPC

Chest symptom/complaint

1.6

8.4

194

1209

WX402

NOMESCO Finland

General anaesthesia

1.3

8.4

530

4064

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.9

8.4

164

R31

ICD-10 Finland

Unspecified haematuria

1.4

8.4

388

2824

TK800

NOMESCO Finland

Hemodialysis

2.1

8.3

414

XG466

NOMESCO Finland

Sleep oxymetry

1.9

8.3

121

652

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

8.3

123

668

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

8.3

568

4408

J46

ICD-10 Finland

Status asthmaticus

2.1

8.3

463

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

8.3

1593

14027

U02

ICPC

Urinary frequency/urgency

1.4

8.3

444

3311

S10

ICPC

Boil/carbuncle

1.7

8.3

168

1008

A03FA02

ATC

cisapride; oral, rectal

1.5

8.3

280

1913

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.3

8.3

341

J34.2

ICD-10 Finland

Deviated nasal septum

1.7

8.3

163

974

SPAT1325

SPAT

Vaccination

1.2

8.2

1363

11818

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

8.2

491

3729

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.9

8.2

110

575

N06AX16

ATC

venlafaxine; oral

1.4

8.2

374

2710

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

8.2

1831

16360

B01AC04

ATC

clopidogrel; oral

1.3

8.2

646

5120

M10.9

ICD-10 Finland

Gout, unspecified

1.5

8.2

257

1728

K62.6

ICD-10 Finland

Ulcer of anus and rectum

3.4

8.2

114

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.5

8.1

243

1616

C01BC04

ATC

flecainide; systemic

1.8

8.1

142

816

-62

ICPC

Administrative procedure

2.0

8.1

101

516

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

8.1

185

1150

K77

ICPC

Heart failure

2.2

8.1

383

B07.9

ICD-10 Finland

Verruca simplex

2.0

8.1

101

518

K86.1

ICD-10 Finland

Other chronic pancreatitis

3.2

8.1

126

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

8.0

1539

13534

D93

ICPC

Irritable bowel syndrome

3.2

8.0

121

G04CA01

ATC

alfuzosin; oral

1.4

8.0

457

3445

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

8.0

185

1153

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

8.0

223

1460

K50.8

ICD-10 Finland

Other Crohn disease

2.9

7.9

160

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

7.9

160

963

N06AB06

ATC

sertraline; oral

1.5

7.9

283

1958

U05

ICPC

Urination problems other

1.7

7.9

173

1062

N06AB04

ATC

citalopram; systemic

1.3

7.9

694

5579

A08

ICPC

Swelling

1.7

7.9

158

948

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

7.9

863

7134

WZA90

NOMESCO Finland

Other doctors statement

1.3

7.8

726

5875

C07AA05

ATC

propranolol; systemic

1.3

7.8

566

4426

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

3.9

7.8

C20

ICD-10 Finland

Malignant neoplasm of rectum

3.8

7.8

M01AX05

ATC

glucosamine; oral

1.3

7.8

820

6746

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

7.8

326

2329

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.5

7.8

227

1503

L84

ICPC

Back syndrome without radiat pain

1.7

7.8

139

807

U07

ICPC

Urine symptom/complaint other

1.6

7.7

211

1372

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.7

7.7

161

975

S83.2

ICD-10 Finland

Tear of meniscus, current

1.6

7.7

205

1327

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

3.9

7.7

Z50.1

ICD-10 Finland

Other physical therapy

1.6

7.7

200

1287

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

5.0

7.7

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.1

7.7

372

C01AA05

ATC

digoxin; systemic

1.4

7.7

301

2124

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

7.7

393

2912

L72.1

ICD-10 Finland

Trichilemmal cyst

1.6

7.7

196

1254

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

7.6

350

2541

D01BA02

ATC

terbinafine; oral; topical

1.3

7.6

884

7354

RD210

NOMESCO Finland

2.4

7.6

269

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

7.6

279

1937

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.9

7.6

106

567

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

7.6

160

972

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

7.6

225

1495

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.4

7.6

105

L08

ICPC

Shoulder symptom/complaint

1.3

7.6

658

5280

S82

ICPC

Naevus/mole

1.4

7.6

397

2951

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.5

7.6

214

1406

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

7.6

618

4918

EBA00

NOMESCO Finland

Extraction of tooth

1.2

7.5

1058

8997

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

7.5

919

7691

-34

ICPC

Blood test

1.9

7.5

105

561

C01DA14

ATC

isosorbide mononitrate; oral

1.3

7.5

632

5046

A28

ICPC

Limited function/disability NOS

1.3

7.5

581

4587

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

10.0

7.5

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.5

7.5

246

1672

D29

ICPC

Digestive symptom/complaint other

2.2

7.5

325

L04AA06

ATC

mycophenolic acid; systemic

2.4

7.5

235

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

7.5

381

2818

SPAT1097

SPAT

Recording of ECG

1.3

7.4

573

4521

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

7.4

3326

31660

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

7.4

531

4146

JFA84

NOMESCO Finland

Laparoscopic excision of lesion of colon

80.2

7.4

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

7.4

195

1260

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.6

7.4

166

1028

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

2.6

7.4

205

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

7.4

421

3175

SPAT1260

SPAT

Consultation of another employee

1.3

7.4

631

5054

L12

ICPC

Hand/finger symptom/complaint

1.4

7.3

439

3337

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

7.3

383

2848

L86

ICPC

Back syndrome with radiating pain

1.6

7.3

191

1231

J01EA01

ATC

trimethoprim; systemic

1.3

7.3

829

6877

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.1

7.3

357

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

7.3

602

4797

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.6

7.3

203

1329

C03AA03

ATC

hydrochlorothiazide; oral

1.4

7.3

374

2773

JG1CG

NOMESCO Finland

Extensive MRI of rectum

3.9

7.2

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

2.1

7.2

363

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

2.4

7.2

237

K51.8

ICD-10 Finland

Other ulcerative colitis

2.8

7.2

154

KED22

NOMESCO Finland

Transurethral resection of prostate

1.5

7.2

232

1568

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3022145) Colonoscopy Study observation

2128

4598

7.43

307.65

1.6

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1168

5084

2.71

172.27

4.5

4.1

ug/l

7.9

24.6

3.96

1000

4181

(3048689) Calprotectin [Mass/mass] in Stool

997

4231

2.70

152.78

2.4

2.1

ug/g

139.4

154.2

0.51

809

3266

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3243

22891

2.24

148.54

7.1

6.4

umol/l

11.7

11.9

0.22

3105

21735

(40768797) Stomach Pathology biopsy report

1245

5977

2.45

146.81

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4178

33067

2.82

145.56

10.0

7.9

u/l

81.5

80.0

0.74

4008

31025

(40768804) Tissue Pathology biopsy report

2609

17070

2.13

142.99

2.6

2.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1938

11341

2.17

141.68

2.9

2.3

mg/l

3.3

3.0

4.43

1724

9636

(3024561) Albumin [Mass/volume] in Serum or Plasma

2867

19519

2.13

140.57

6.1

4.9

g/l

35.1

34.9

1.10

2713

18026

(3013650) Neutrophils [#/volume] in Blood by Automated count

3306

24111

2.15

130.83

10.3

9.1

e9/l

4.2

0.12

2900

20939

(3001604) Monocytes [#/volume] in Blood

2939

20589

2.07

128.49

7.0

5.7

e9/l

0.6

0.74

2545

17548

(3006315) Basophils [#/volume] in Blood

2951

20709

2.07

128.34

7.0

5.7

e9/l

0.0

0.03

2550

17670

(3019198) Lymphocytes [#/volume] in Blood

2982

21076

2.06

126.28

7.1

5.8

e9/l

1.9

0.04

2587

18300

(3013115) Eosinophils [#/volume] in Blood

3013

21378

2.07

126.20

7.3

5.9

e9/l

0.2

0.29

2632

18507

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2443

16435

1.97

114.65

3.9

2.8

ug/l

132.3

154.0

3.14

2273

14953

(3013707) Erythrocyte sedimentation rate by Westergren method

3878

31004

2.22

108.58

5.3

4.2

mm/h

14.8

13.6

4.27

3638

28396

(3007164) IgA [Mass/volume] in Serum or Plasma

1273

6967

2.12

104.62

1.4

1.5

g/l

2.5

2.6

0.82

717

4074

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1386

7841

2.07

104.18

1.3

1.2

u/ml

1.6

1.8

0.16

308

1996

(3022948) Iron [Moles/volume] in Serum or Plasma

1287

7113

2.10

102.79

3.3

2.6

umol/l

11.9

12.5

2.02

1211

6580

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2658

18958

1.88

98.92

2.4

2.1

pmol/l

94.2

94.0

0.06

1506

9736

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2834

20757

1.87

95.63

7.5

6.1

mmol/l

1.2

0.21

2624

18669

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1199

6624

2.07

94.77

3.3

2.5

g/l

2.3

2.76

1132

6128

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1144

6222

2.10

94.24

3.3

2.6

21.0

22.2

1.75

998

5253

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2050

13754

1.85

89.84

2.9

2.6

u/l

59.3

58.7

0.12

1927

12654

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2999

22779

1.82

85.46

9.0

6.9

mmol/l

1.2

0.90

2693

19156

(3033658) Prothrombin time (PT) actual/Normal

1699

10914

1.85

84.29

5.3

4.0

87.6

86.8

0.57

1674

10657

(3031040) Bacteria [#/volume] in Urine by Automated count

3521

28166

1.90

84.13

6.1

4.8

e6/l

1127.2

1869.3

0.29

444

(3044640) Blood type and Crossmatch panel - Blood

2031

13844

1.80

82.42

3.0

2.5

—

(3019069) Monocytes/100 leukocytes in Blood

2638

19461

1.77

81.15

7.6

6.3

8.8

8.9

0.26

2494

18068

(3018010) Neutrophils/100 leukocytes in Blood

2646

19545

1.77

80.96

7.1

5.9

58.7

58.0

2.27

2480

18121

(3037467) Urinalysis macro (dipstick) panel - Urine

3586

29000

1.89

80.93

5.8

4.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4560

40427

2.92

80.55

23.6

16.4

mg/l

25.8

0.00

3918

32706

(3006504) Eosinophils/100 leukocytes in Blood

2621

19367

1.76

79.53

7.3

6.0

2.8

2.9

0.27

2477

17918

(40758558) Short blood count panel - Blood

1634

10597

1.81

77.04

7.6

6.8

—

(3002030) Lymphocytes/100 leukocytes in Blood

2656

19828

1.74

76.51

7.4

6.1

26.1

26.8

2.24

2491

18279

(3019309) Folate [Moles/volume] in Red Blood Cells

1454

9148

1.84

75.40

1.8

nmol/l

1153.3

1170.7

0.28

1154

6827

(3011397) Hemoglobin [Presence] in Urine by Test strip

1543

9895

1.82

75.11

5.0

3.8

—

(3022096) Basophils/100 leukocytes in Blood

2541

18840

1.73

74.05

7.3

6.0

0.7

0.14

2399

17445

(42870588) Differential panel, method unspecified - Blood

2076

14558

1.74

73.96

6.8

5.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3261

25937

1.77

73.76

6.1

4.8

mmol/l

6.9

6.8

0.99

3085

24412

(3027945) Reticulocytes/100 erythrocytes in Blood

993

5555

1.99

73.46

2.6

2.4

1.8

0.77

892

4879

(3032080) INR in Blood by Coagulation assay

2547

19081

1.70

69.82

12.3

10.3

inr

1.3

0.30

583

5259

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1603

10620

1.76

68.51

2.9

2.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2631

19984

1.69

67.58

4.6

4.2

—

(3035350) Ketones [Presence] in Urine by Test strip

2656

20245

1.68

67.12

4.9

3.9

estimate

0.0

0.50

368

3758

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

541

2471

2.34

67.06

2.8

2.5

—

(3009261) Glucose [Presence] in Urine by Test strip

2684

20550

1.68

66.37

5.0

3.9

estimate

0.0

1.34

360

3689

(3014576) Chloride [Moles/volume] in Serum or Plasma

1023

5961

1.91

66.30

7.3

6.7

mmol/l

104.3

104.4

0.05

1012

5820

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

508

2276

2.37

65.76

1.8

1.7

g/l

1.6

0.24

450

1944

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1237

7682

1.82

65.34

3.4

2.9

e6/l

1.0

1.2

1.20

747

4486

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2019

14424

1.68

64.48

3.5

3.1

ng/l

1639.5

1558.9

0.34

1798

12519

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

741

3941

2.04

62.27

2.8

2.4

u/l

48.9

50.6

0.04

640

3362

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3644

30544

1.76

61.91

4.5

4.0

pmol/l

15.0

0.17

3350

27299

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3106

24962

1.67

61.44

3.9

3.2

u/l

62.7

54.5

3.12

2877

22778

(3021601) Nitrite [Presence] in Urine by Test strip

2633

20298

1.64

61.31

6.7

5.2

estimate

0.0

0.50

384

3795

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2332

17463

1.64

60.79

4.7

3.9

ng/l

49.4

77.3

0.54

1785

13131

(3021960) Folate [Moles/volume] in Serum or Plasma

1615

11021

1.70

60.30

1.7

1.6

nmol/l

20.7

20.4

0.23

1431

9291

(3023520) Reticulocytes [#/volume] in Blood

770

4233

1.97

58.66

2.8

2.5

e9/l

71.1

69.0

0.81

602

3220

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

934

5487

1.87

58.16

4.1

4.2

u/l

228.1

244.1

4.53

886

5170

(3030467) Casts [#/volume] in Urine by Automated count

1764

12437

1.65

57.45

4.0

3.3

e6/l

0.4

0.5

0.64

1372

9480

(40761511) CBC panel - Blood by Automated count

4559

41485

2.48

56.68

22.2

15.6

—

(3018095) Leukocytes [#/volume] in Urine

2091

15465

1.62

55.66

4.8

3.9

e6/l

65.0

108.8

2.97

1527

11242

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4191

37050

1.92

54.66

5.7

4.8

mu/l

2.0

2.1

1.50

3918

33269

(3019550) Sodium [Moles/volume] in Serum or Plasma

4642

42704

2.75

54.40

27.9

19.2

mmol/l

139.6

139.7

0.22

4573

41650

(36304419) Bacteria [Presence] in Urine

1687

11943

1.63

52.99

3.9

3.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4642

42786

2.71

52.64

28.1

19.4

mmol/l

4.0

0.02

4566

41666

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1115

7134

1.73

51.30

3.7

3.1

e6/l

2.4

2.2

0.26

634

3970

(40761535) Cells panel - Urine sediment

693

3837

1.94

51.18

4.5

3.6

—

(3000991) Gas panel - Venous blood

696

3869

1.93

50.77

8.3

8.0

—

(3023368) Bacteria identified in Blood by Culture

1782

12898

1.60

50.47

5.1

4.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

627

3376

1.98

50.18

1.8

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2033

15214

1.58

49.70

3.8

3.4

mmol/l

2.4

0.90

1743

13035

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1324

8937

1.66

49.58

2.1

1.7

mg/l

1.3

1.4

0.40

1017

6939

(3026493) Urate [Moles/volume] in Serum or Plasma

1630

11615

1.61

48.91

3.2

2.8

umol/l

3306.0

5615.2

1.69

1427

9863

(3019150) Specific gravity of Urine by Refractometry

1328

9004

1.65

48.72

5.5

4.4

kg/l

1.0

0.67

219

1371

(3014765) Yersinia sp identified in Stool by Organism specific culture

285

1125

2.63

48.03

1.3

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

645

3563

1.93

47.75

4.8

3.8

ng/l

110.7

94.4

3.54

569

3003

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

815

4857

1.81

47.52

3.1

2.7

umol/l

9.1

0.01

720

4243

(42529406) Shigella sp [Presence] in Stool by Culture

285

1133

2.61

47.34

1.3

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

314

1319

2.48

46.46

1.5

1.4

ug/g

266.7

266.2

0.01

188

794

(3014111) Lactate [Moles/volume] in Serum or Plasma

715

4123

1.86

46.29

6.8

6.6

mmol/l

1.3

1.4

0.96

682

3975

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

279

1113

2.60

46.00

1.3

1.2

—

(3018418) pH of Serum or Plasma

1828

13534

1.56

45.74

5.2

4.1

7.4

0.19

218

2548

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4631

42977

2.49

45.55

15.3

11.3

u/l

25.3

25.6

0.47

4545

41219

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4633

43004

2.50

45.54

28.1

19.5

umol/l

86.5

81.0

12.54

4633

42991

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4267

38481

1.86

44.73

7.9

6.4

mmol/mol

41.1

40.6

3.04

4027

35133

(36660697) Celiac disease serology panel - Serum

537

2847

2.00

44.65

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4257

38450

1.83

43.19

20.6

15.5

ml/min/173m2

73.9

75.4

4.96

3638

31930

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2221

17318

1.52

42.94

2.6

2.2

nmol/l

78.1

79.3

1.19

2001

15200

(3004716) Salmonella sp identified in Stool by Organism specific culture

342

1556

2.29

42.20

1.4

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1241

8535

1.61

41.89

3.5

3.1

mmol/l

2.5

0.32

1076

7468

(3003396) Base excess in Arterial blood by calculation

884

5575

1.72

41.83

6.9

mmol/l

1.0

1.1

0.14

697

4343

(3027801) Oxygen [Partial pressure] in Arterial blood

886

5598

1.71

41.62

6.9

kpa

11.8

12.1

1.10

834

5345

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

886

5601

1.71

41.53

6.9

kpa

5.1

0.07

835

5350

(3021447) Carbon dioxide [Partial pressure] in Venous blood

727

4347

1.79

41.46

5.1

3.7

kpa

5.8

0.14

703

4223

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1839

13870

1.52

41.04

2.3

2.2

u/l

192.6

202.2

0.24

1724

12930

(3002582) Erythrocytes [#/volume] in Urine

1801

13530

1.52

40.91

4.2

3.4

e6/l

82.9

74.5

0.09

1405

10518

(3003458) Phosphate [Moles/volume] in Serum or Plasma

931

5996

1.68

40.62

7.8

5.8

mmol/l

1.1

1.0

1.10

877

5545

(3003327) Ova and parasites identified in Stool by Light microscopy

265

1095

2.50

40.56

1.8

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

714

4295

1.78

39.77

2.5

2.2

g/l

0.2

3.51

672

3988

(3002032) Base excess in Venous blood by calculation

719

4337

1.77

39.67

5.2

3.7

mmol/l

1.7

2.0

1.43

607

3513

(3022217) INR in Platelet poor plasma by Coagulation assay

1003

6624

1.65

39.59

34.3

27.7

inr

1.6

1.4

1.53

950

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

897

5789

1.67

38.62

10.9

7.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

693

4167

1.77

38.57

2.6

g/l

66.2

0.01

634

3760

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

712

4334

1.75

37.93

2.6

2.4

ug/l

6.1

6.9

0.68

632

3756

(3007461) Platelets [#/volume] in Blood

4688

44147

2.54

37.49

36.4

24.1

e9/l

243.2

244.2

0.42

4616

42914

(3012544) pH of Venous blood

732

4506

1.73

37.44

5.2

3.7

—

7.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

4689

44164

2.54

37.42

36.7

24.3

g/l

131.3

134.1

29.36

4647

43434

(3024731) MCV [Entitic volume]

4688

44152

2.53

37.39

36.3

24.1

91.7

91.6

0.84

4647

43421

(3035941) MCH [Entitic mass]

4688

44154

2.53

37.35

36.2

24.0

30.4

0.97

4647

43423

(3026361) Erythrocytes [#/volume] in Blood

4688

44156

2.53

37.31

36.4

24.1

e12/l

4.4

14.82

4605

42749

(3010813) Leukocytes [#/volume] in Blood

4688

44163

2.53

37.17

36.5

24.2

e9/l

6.9

6.8

0.84

4608

42743

(3014007) Fractional oxyhemoglobin in Arterial blood

540

3044

1.87

37.08

8.2

8.5

93.8

0.01

540

3031

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1057

7175

1.60

37.00

2.5

2.0

30.3

30.0

0.95

1027

6966

(3021589) Normoblasts [#/volume] in Blood

2275

18193

1.47

36.71

11.7

10.2

e9/l

0.0

1.15

1859

14824

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1719

13015

1.49

36.51

3.8

3.3

u/l

33.6

37.2

1.20

1621

12271

(3009542) Hematocrit [Volume Fraction] of Blood

3930

35145

1.60

36.28

25.8

17.7

38.1

39.0

6.64

2601

22613

(3044889) 12 lead EKG panel

3447

29955

1.51

36.14

5.1

4.2

—

(3042936) Bacteria identified in Isolate by Culture

954

6371

1.62

35.55

2.2

2.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

490

2727

1.89

34.93

1.3

1.2

—

(3016502) Oxygen saturation in Arterial blood

786

5030

1.67

34.60

7.3

7.2

95.5

0.00

763

4848

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4349

40046

1.78

34.46

6.1

5.1

mmol/l

6.2

6.1

4.92

4061

35933

(3020779) Urea [Moles/volume] in Serum or Plasma

687

4276

1.71

33.49

9.7

7.0

mmol/l

11.7

10.6

3.34

662

4064

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

338

1678

2.09

33.40

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4417

40931

1.83

33.26

6.2

5.4

mmol/l

2.6

7.95

4150

37068

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

459

2543

1.89

33.12

7.9

8.8

mmol/l

24.3

0.02

412

2371

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

260

1169

2.29

32.91

1.7

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2491

20521

1.44

32.90

2.7

2.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

345

1740

2.06

32.66

3.5

3.4

u/ml

2539.7

3185.1

0.10

296

1477

(4010399)

537

3158

1.79

31.90

1.6

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

589

3562

1.74

31.75

4.1

3.1

kpa

4.6

4.5

0.26

568

3447

(3000850) Epithelial cells [#/volume] in Urine

1308

9580

1.50

31.72

2.9

2.7

e6/l

4.6

5.0

0.47

1132

8396

(3004588) Protein electrophoresis panel - Serum or Plasma

578

3485

1.75

31.48

2.2

2.5

—

(3012516) Albumin [Mass/volume] in Urine

1807

14113

1.44

31.44

3.8

3.3

mg/l

516.4

365.3

0.63

1217

8908

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4325

39957

1.72

31.30

5.5

4.8

mmol/l

4.4

4.5

7.57

4055

36395

(3020682) Albumin/Creatinine [Ratio] in Urine

1887

14879

1.44

31.07

4.5

4.0

mg/mmol

14.8

9.1

4.09

1283

9337

(3020961) Endomysium IgA Ab [Titer] in Serum

306

1505

2.10

30.96

1.1

titre

142.0

229.8

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

717

4601

1.65

30.95

7.7

7.6

g/l

118.0

120.4

2.36

701

4438

(3026782) Osmolality of Urine

1221

8871

1.50

30.61

3.4

2.9

mosm/kgh2o

546.0

548.7

0.16

1042

7556

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

335

1723

2.01

30.01

3.7

2.9

u/ml

0.3

1.36

190

994

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4289

39627

1.67

29.88

5.4

4.7

mmol/l

1.4

1.5

2.50

4001

35818

(3000492) Spirometry study

571

3485

1.72

29.69

1.6

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4174

38318

1.61

29.67

4.9

4.2

mmol/l

1.4

1.3

6.55

3852

34292

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

394

2151

1.90

29.65

5.5

3.9

mmol/l

24.0

24.2

0.41

347

1918

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1053

7459

1.52

29.65

3.6

3.2

mmol/l

0.8

2.53

978

6918

(3026008) Bacteria identified in Urine by Culture

1764

13829

1.43

29.57

4.0

3.3

—

(3009508) Creatinine [Moles/volume] in Urine

1824

14400

1.43

29.35

3.7

3.2

mmol/l

7.3

0.00

1542

11910

(3007853) Bacteria identified in Skin by Aerobe culture

763

5042

1.61

29.13

2.1

1.8

—

(3037522) Nuclear Ab [Titer] in Serum

768

5094

1.60

28.84

1.4

1.3

titre

461.4

511.9

0.40

153

1102

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

486

2898

1.75

27.36

1.8

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1920

15436

1.40

27.25

5.5

4.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1062

7663

1.49

27.02

2.1

1.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

779

5260

1.57

26.96

2.0

1.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

570

3590

1.67

26.19

2.9

2.7

ml/min/173m2

61.6

62.0

0.07

267

1491

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

777

5284

1.56

25.98

2.0

1.8

—

(3000494) Fungus identified in Specimen by Culture

740

4991

1.57

25.63

1.5

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

270

1375

2.02

24.83

1.7

1.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

375

2148

1.81

24.13

3.6

2.6

0.6

0.7

0.21

362

2050

(3009445) Proteinase 3 Ab [Units/volume] in Serum

341

1900

1.85

24.00

1.5

u/ml

4.5

19.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

915

6545

1.49

23.95

1.3

iu/ml

32.0

37.2

0.55

283

2007

(3020891) Body temperature

345

1942

1.84

23.50

5.6

4.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

348

1977

1.82

23.00

2.1

2.4

g/l

7.5

0.08

248

1450

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

347

1973

1.82

22.86

2.2

2.4

g/l

4.0

3.8

1.11

235

1392

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

347

1975

1.81

22.79

2.2

2.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1189

9017

1.42

22.70

4.7

4.0

ng/l

343.8

464.2

0.45

1019

7574

(3029937) Albumin [Presence] in Urine by Test strip

1424

11158

1.39

22.43

5.5

4.3

estimate

0.0

0.88

354

3637

(3025941) Bacteria identified in Stool by Culture

362

2098

1.78

22.37

1.5

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

463

2879

1.67

22.21

4.8

3.2

g/l

124.3

128.1

2.89

455

2807

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

867

6221

1.48

22.17

1.3

1.2

u/ml

13.0

14.0

0.11

288

2236

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

303

1677

1.86

21.77

2.4

g/l

1.0

1.1

0.01

257

1425

(3037121) Protein [Mass/volume] in Urine

287

1565

1.89

21.60

3.3

3.0

g/l

0.4

0.3

0.49

141

636

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

324

1842

1.81

21.34

2.1

2.4

g/l

10.2

0.03

263

1536

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

322

1836

1.81

21.01

2.2

2.4

g/l

3.2

3.1

1.35

239

1421

(46235355) HIV 1 and 2 tests - Meaningful Use set

627

4282

1.53

20.21

1.7

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

535

3529

1.58

20.13

1.7

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

277

1528

1.86

20.11

2.1

2.2

g/l

36.9

37.5

0.77

231

1298

(3002256) Pathology report gross observation

795

5712

1.47

20.00

1.4

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

480

3095

1.61

19.87

2.5

2.7

g/l

10.5

0.03

451

2806

(3003338) MCHC [Mass/volume]

3567

32476

1.36

19.67

33.1

21.5

g/l

330.7

331.8

9.90

3540

32222

(3002385) Erythrocyte distribution width [Ratio]

3564

32448

1.36

19.63

29.0

20.0

14.1

13.8

16.07

3508

31710

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

265

1459

1.86

19.35

2.2

2.3

g/l

0.0

0.60

235

1327

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

250

1353

1.89

19.26

2.2

2.3

g/l

0.0

0.50

220

1226

(3028026) IgM [Mass/volume] in Serum or Plasma

395

2451

1.67

19.03

2.0

1.9

g/l

1.4

0.12

366

2202

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

245

1328

1.89

18.79

2.2

2.3

g/l

0.0

0.00

219

1222

(3019060) Gas panel - Arterial blood

498

3292

1.57

18.51

5.0

4.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

191

956

2.04

18.46

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

191

956

2.04

18.46

1.4

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

425

2719

1.62

18.12

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

555

3779

1.53

18.04

1.7

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

281

1619

1.78

17.70

2.3

2.2

ug/l

294.5

579.5

1.41

260

1534

(3036481) Cortisol [Moles/volume] in Serum or Plasma

537

3652

1.53

17.53

2.3

2.2

nmol/l

364.2

374.6

0.59

499

3316

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

260

1471

1.81

17.40

1.5

titre

63.3

280.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

281

1654

1.74

16.44

2.8

3.5

mg/l

81.1

89.8

0.08

249

1346

(3036489) Thrombin time

256

1468

1.79

16.39

2.2

1.9

22.3

21.5

0.82

226

1310

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

176

895

2.00

16.31

1.4

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

280

1651

1.74

16.28

2.8

3.5

mg/l

42.4

56.5

0.83

249

1345

(21494890) Protein electrophoresis panel - 24 hour Urine

124

553

2.27

16.11

1.7

2.1

—

(3013512) EKG study

1637

13610

1.30

16.11

5.0

4.3

—

(3037756) Immunofixation for Serum or Plasma

205

1104

1.89

16.06

1.4

1.7

—

(3043409) Potassium [Moles/volume] in Arterial blood

257

1485

1.77

16.04

5.0

3.9

mmol/l

3.9

0.93

252

1385

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

274

1613

1.74

16.02

2.8

3.5

ratio

6.1

3.7

0.25

120

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

178

915

1.98

16.00

1.1

u/ml

9.5

5.2

0.31

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

541

3756

1.50

15.95

1.7

1.6

1.5

0.93

450

3200

(4035726)

572

4026

1.48

15.74

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

173

888

1.98

15.63

1.2

—

(3006462) Nitrate [Presence] in Urine

215

3.05

15.40

4.6

4.0

—

(40768443) Skin Pathology biopsy report

318

1971

1.66

15.37

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

250

1454

1.76

15.26

1.1

u/ml

2.8

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

248

1445

1.75

15.05

1.4

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

208

1152

1.84

14.95

1.5

g/l

1.2

0.07

199

1088

(40760892) CBC W Ordered Manual Differential panel - Blood

1071

8462

1.34

14.93

5.2

4.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

639

4638

1.43

14.93

1.4

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

300

1850

1.66

14.79

5.5

4.0

mmol/l

24.8

24.9

0.27

280

1693

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

193

1054

1.87

14.51

2.6

3.4

u/ml

200.3

824.2

1.46

181

963

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

201

1114

1.84

14.42

1.4

1.5

g/l

0.2

0.65

190

1052

(3024980) IgG subclass 4 [Mass/volume] in Serum

126

597

2.14

14.16

1.8

1.6

g/l

0.7

0.8

1.31

100

449

(4211845)

233

2.86

13.97

4.5

3.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

223

2.89

13.87

1.5

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

229

1338

1.75

13.78

3.7

3.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

355

2325

1.57

13.67

4.7

3.4

mmol/l

24.9

25.2

0.94

348

2258

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

221

2.87

13.50

1.6

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

364

2406

1.55

13.46

1.3

au/ml

56.7

56.4

0.01

111

(3027456) Digoxin [Moles/volume] in Serum or Plasma

191

1066

1.82

13.42

3.3

3.1

nmol/l

0.8

0.37

148

809

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1936

16719

1.26

13.37

6.2

5.4

ug/l

2.8

3.8

1.26

1769

14881

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

198

1120

1.80

13.31

1.5

1.6

iu/ml

12.8

8.8

0.11

250

(3022313) Gas panel - Capillary blood

333

2167

1.58

13.19

5.3

3.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

327

2125

1.58

13.03

1.4

1.3

u/ml

207.6

207.0

0.01

300

1938

(40760888) Immunoglobulin light chains.free panel - Serum

213

1240

1.75

12.99

2.8

3.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

188

1057

1.81

12.91

2.5

2.4

211.9

204.4

0.53

178

1007

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

392

2664

1.51

12.75

2.4

au/ml

26.5

23.0

0.21

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

200

1151

1.77

12.70

2.4

2.1

92.4

89.2

1.31

192

1086

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

169

929

1.85

12.49

1.7

1.6

—

(3044927) Protein electrophoresis panel - Urine

110

520

2.14

12.48

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

176

983

1.82

12.36

3.0

2.7

umol/l

32.4

34.8

0.55

150

827

(3038177) Helicobacter pylori Ab [Presence] in Serum

110

526

2.12

12.13

1.4

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

270

1718

1.61

11.77

2.9

2.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

186

1079

1.75

11.52

1.3

1.2

titre

120.0

92.4

0.25

(3006270) Folate [Moles/volume] in Blood

393

2.26

11.51

1.3

1.2

nmol/l

329.7

345.4

0.32

314

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

195

1147

1.73

11.50

3.3

2.4

g/l

3.8

3.6

0.80

188

1090

(3034770) Mitochondria Ab [Titer] in Serum

187

1087

1.75

11.50

1.3

1.2

titre

1742.9

1031.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

460

2.15

11.36

2.9

3.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

409

2875

1.46

11.25

4.9

3.7

mmol/l

1.5

1.9

1.46

318

2143

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1567

13401

1.25

11.25

5.3

4.6

21.7

22.1

0.39

850

7039

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

117

593

2.00

11.06

1.2

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

434

3101

1.44

10.94

8.2

6.7

mmol/l

24.7

24.6

0.14

415

2896

(3021879) Hepatitis B virus core Ab [Presence] in Serum

330

2241

1.51

10.78

1.4

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

311

2.37

10.67

1.2

titre

335.0

81.2

—

(3009343) pH of Capillary blood

418

2983

1.44

10.61

5.0

3.7

7.4

0.28

370

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

137

746

1.86

10.49

1.6

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

375

2637

1.46

10.29

9.1

9.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

421

3025

1.43

10.29

5.0

3.7

kpa

5.2

0.24

399

2791

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

178

1055

1.71

10.26

1.9

mg/l

13.0

12.0

0.84

166

960

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

531

3974

1.38

10.24

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

258

2.46

10.06

2.5

2.2

umol/l

20.9

23.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

148

842

1.78

9.85

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

145

820

1.79

9.85

7.1

4.8

iu/ml

506.3

2404.8

0.50

118

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1140

9525

1.26

9.79

3.4

3.2

ug/l

0.8

0.09

884

6757

(3024928) Oxygen saturation in Venous blood

164

966

1.72

9.68

4.5

2.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

177

2.73

9.48

2.9

2.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

258

1718

1.53

9.27

1.9

1.8

u/l

37.9

38.5

0.20

217

1478

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

169

1018

1.68

9.21

1.5

1.4

—

(3042733) HLA Ab [Presence] in Serum

3.38

9.16

5.6

4.7

—

(4062490)

373

2.14

9.10

1.4

1.3

—

(3019225) pH of Specimen

617

4816

1.32

8.98

5.6

4.6

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

488

1.97

8.74

1.6

1.3

u/l

213.3

344.9

3.64

465

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

110

594

1.87

8.72

1.2

u/ml

295.9

299.2

0.04

354

(3026250) Tacrolimus [Mass/volume] in Blood

141

2.85

8.62

37.0

31.3

ug/l

6.7

7.3

0.80

126

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

170

1045

1.65

8.60

1.3

1.2

u/ml

15.1

41.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

170

1049

1.64

8.48

1.8

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

371

2.09

8.45

1.4

1.3

g/l

6.7

7.1

0.44

257

(3028192) IgG subclass 2 [Mass/volume] in Serum

371

2.09

8.45

1.4

1.3

g/l

2.8

2.9

0.00

258

(3024139) IgG subclass 3 [Mass/volume] in Serum

371

2.09

8.45

1.4

1.3

g/l

0.6

0.4

0.38

258

(3023199) Leukocytes [#/volume] in Pleural fluid

115

639

1.82

8.34

1.8

1.5

e6/l

1292.1

1825.2

1.09

471

(1761868) Lipid panel - Serum or Plasma

1043

12288

0.81

8.31

3.4

3.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

295

2.22

8.29

1.2

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

196

1265

1.57

8.14

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

158

972

1.65

7.99

1.3

1.2

u/ml

1.7

3.3

1.82

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

115

648

1.79

7.98

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

268

2.25

7.97

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

268

2.25

7.97

1.2

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

124

715

1.75

7.96

1.2

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

269

2.25

7.90

1.2

1.1

—

(3049717) Cytology report of Urine Cyto stain

289

2036

1.45

7.89

2.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

183

2.53

7.88

1.3

—

(3036603) Volume of Urine

302

2.17

7.85

1.4

1.7

2235.8

1863.0

1.00

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

109

609

1.81

7.79

1.7

1.4

u/ml

119.1

123.0

0.13

125

(40768446) Kidney Pathology biopsy report

138

2.77

7.79

1.6

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

271

2.23

7.77

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

271

2.23

7.77

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

271

2.23

7.77

1.2

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

183

1177

1.58

7.73

1.5

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

158

984

1.63

7.63

1.3

1.2

u/ml

10.2

5.4

0.26

166

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

144

876

1.66

7.63

1.4

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

122

710

1.74

7.60

1.5

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

390

2914

1.37

7.59

2.7

2.1

nmol/l

11.0

12.3

2.63

334

2511

(3028308) Erythrocytes [#/volume] in Pleural fluid

103

573

1.81

7.49

1.8

1.4

e6/l

35745.0

71919.7

1.05

340

(3025468) Yersinia sp identified in Specimen by Organism specific culture

106

597

1.79

7.40

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

106

598

1.79

7.36

1.6

1.4

—

(3045788) Cell count panel - Pleural fluid

491

1.87

7.30

1.9

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

106

601

1.78

7.25

1.6

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

135

819

1.67

7.25

1.2

u/ml

3.4

5.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

107

613

1.76

7.07

1.6

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

578

4619

1.29

7.02

1.4

—

(40768441) Liver Pathology biopsy report

290

2.12

7.00

1.6

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

105

601

1.76

6.97

1.6

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

139

861

1.63

6.90

1.2

1.1

—

(4094501)

176

1153

1.55

6.90

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

105

605

1.75

6.82

1.6

1.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.78

6.80

1.4

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

475

1.85

6.75

3.8

3.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

121

728

1.68

6.73

1.8

1.5

g/l

30.2

32.1

1.06

108

653

(3051651) Icteric interference index of Serum or Plasma

269

2.13

6.68

4.5

3.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

107

624

1.73

6.67

2.9

2.1

mg/l

26.6

25.0

0.10

156

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

385

1.94

6.66

1.1

1.0

u/ml

2.9

2.0

0.43

131

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

110

649

1.71

6.58

2.2

1.9

pmol/l

182.1

196.7

0.66

608

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

194

1313

1.50

6.55

1.6

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

171

1128

1.53

6.52

1.6

e6/l

15062.8

14584.6

0.05

126

803

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

178

1185

1.52

6.50

2.2

2.3

ug/min

203.1

93.7

1.64

105

695

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

112

2.78

6.46

6.6

1.8

ug/l

1.3

1.2

0.10

103

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

254

2.14

6.40

1.2

u/l

35.1

23.2

0.56

220

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

558

1.75

6.36

1.1

g/l

1.5

0.60

502

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

119

725

1.66

6.34

1.2

u/ml

44.3

45.4

0.02

(3000093) Morphology [Interpretation] in Blood Narrative

449

1.84

6.33

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

385

1.91

6.33

1.6

1.3

u/l

8.0

13.1

3.47

351

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

134

848

1.60

6.14

1.3

1.2

—

5.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1134

9869

1.19

6.14

1.8

1.7

pmol/l

36177217.1

25896847.0

0.25

973

8032

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

299

2220

1.37

6.09

3.3

3.2

pmol/l

4.3

4.4

0.40

249

1941

(3051611) Lipemic interference index of Serum or Plasma

477

1.80

6.08

4.3

3.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

471

1.80

6.03

1.7

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

161

1068

1.52

6.01

4.0

2.8

mg/l

1.9

1.7

1.62

153

960

(3012441) Differential panel - Pleural fluid

546

1.74

5.99

1.6

1.5

—

(3003694) ABO and Rh group [Type] in Blood

1188

10413

1.19

5.90

1.3

—

(3024471) HLA-A [Type]

101

2.78

5.88

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

204

2.22

5.87

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

491

1.76

5.82

1.7

1.4

mmol/l

6.7

6.3

0.56

455

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

231

2.13

5.81

1.8

1.7

u/field

4.1

2.4

0.41

165

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

259

1896

1.39

5.77

3.4

4.0

u/ml

43.8

68.6

1.65

248

1823

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

442

1.80

5.73

1.7

1.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

266

2.04

5.71

1.2

u/l

113.2

87.1

0.79

235

(3009214) Lutropin [Units/volume] in Serum or Plasma

109

668

1.65

5.71

1.5

1.3

u/l

12.4

11.3

0.25

542

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

102

617

1.67

5.63

1.1

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

211

1498

1.43

5.62

1.7

1.6

—

(3024932) HLA-DR beta [Type]

2.76

5.62

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

992

0.51

5.61

3.8

3.7

mg/l

31.7

28.8

0.21

620

(44806118)

475

1.76

5.59

1.6

1.4

—

(44790049)

475

1.76

5.59

1.6

1.4

—

(44790047)

475

1.76

5.59

1.6

1.4

—

(44790048)

475

1.76

5.59

1.6

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

533

4341

1.26

5.52

3.5

2.9

ng/l

269.6

208.5

1.91

486

3982

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

462

1.77

5.52

1.2

u/l

54.5

61.0

0.63

314

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

178

2.26

5.47

2.2

2.7

—

31.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

516

1.72

5.46

1.2

u/ml

3.3

4.9

1.10

224

(3047189) Immunofixation for 24 hour Urine

259

2.02

5.36

1.4

1.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

135

888

1.54

5.28

2.0

1.8

nmol/l

42.7

43.5

0.16

129

846

(3025130) Human papilloma virus identified in Specimen

296

1.94

5.24

1.6

1.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

163

2.28

5.20

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

487

1.72

5.16

1.5

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

526

1.69

5.11

1.2

u/ml

2.1

3.7

0.86

165

(3017704) Immunofixation for Urine

278

1.95

5.10

1.4

1.6

—

(3021788) Differential panel - Synovial fluid

125

817

1.54

5.05

1.4

1.5

—

(3017181) Myelocytes/100 leukocytes in Blood

464

3759

1.26

5.04

4.4

4.0

0.9

0.12

142

1131

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

123

804

1.54

4.98

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

235

2.01

4.83

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

235

2.01

4.83

1.4

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

249

1.98

4.82

1.6

1.7

—

(21494434) Karyotype in Bone marrow

445

1.72

4.78

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

257

1.96

4.76

1.5

1.8

—

(3022689) Creatine [Moles/volume] in Urine

126

2.39

4.71

1.5

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

238

1.98

4.68

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

269

2052

1.33

4.66

2.1

1.9

ug/l

1.8

2.4

0.62

240

1800

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

360

1.79

4.64

1.9

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

146

2.27

4.62

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

205

2.06

4.62

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

280

2152

1.32

4.61

1.2

iu/ml

113.3

140.2

0.53

104

761

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.34

4.60

2.3

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

674

5734

1.20

4.60

4.9

4.8

32.4

33.1

0.82

505

3733

(3051593) INR in Capillary blood by Coagulation assay

256

1.92

4.48

8.0

12.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

586

1.60

4.45

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

102

658

1.56

4.42

6.8

6.6

mg/l

12.6

12.0

0.71

605

(3015171) Extractable nuclear Ab [Units/volume] in Serum

199

1462

1.38

4.42

1.2

u/ml

0.5

1.3

1.22

141

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

426

1.70

4.40

1.2

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

331

1.79

4.34

2.1

1.8

u/l

324.3

1617.0

0.97

132

(3011985) Renin [Units/volume] in Plasma

575

1.59

4.31

1.2

1.4

mu/l

86.2

57.4

0.67

509

(3033705) Calcium.ionized [Moles/volume] in Venous blood

600

1.58

4.27

2.5

2.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

185

1352

1.38

4.25

1.6

—

(3020491) Glucose [Moles/volume] in Blood

304

1.82

4.25

1.6

2.0

mmol/l

7.3

6.9

0.32

200

(3035880) pH of Pleural fluid

297

1.83

4.24

1.6

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

393

1.71

4.24

1.4

1.6

u/ml

27.7

23.7

0.31

(3042111) Morphology [Interpretation] in Bone marrow Narrative

128

876

1.47

4.23

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

409

1.70

4.20

1.3

nmol/l

1.7

1.5

0.91

365

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

379

1.72

4.20

1.2

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

350

1.75

4.17

1.6

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

344

1.75

4.12

1.6

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

257

1.88

4.11

2.8

2.0

e6/l

716.0

596.0

0.42

114

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

397

1.70

4.10

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

397

1.70

4.10

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

397

1.70

4.10

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

222

1.95

4.10

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

222

1.95

4.10

1.1

1.0

—

(3025159) Blasts/100 leukocytes in Blood

407

3330

1.24

4.09

4.6

4.1

0.0

0.3

1.27

107

879

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

2.71

4.08

2.3

2.7

—

72.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

433

3569

1.23

4.06

4.6

4.0

0.1

0.21

122

1055

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

8.01

4.06

1.8

2.5

mg/l

2.5

3.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

264

2051

1.30

4.05

5.3

5.2

1.6

0.07

251

1924

(3017315) Amylase [Enzymatic activity/volume] in Urine

216

1.95

4.05

1.2

u/l

273.6

339.0

0.29

198

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

347

1.74

4.01

1.2

—

(3017732) Neutrophils [#/volume] in Blood

347

2795

1.26

4.00

3.1

3.3

e9/l

4.2

0.01

256

2037

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

2.60

3.96

2.6

3.0

mg/l

6.5

6.7

0.07

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

620

1.54

3.95

1.7

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

184

2.02

3.92

3.2

2.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

260

2026

1.30

3.91

5.4

5.2

0.8

0.9

0.98

247

1904

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

117

800

1.47

3.91

1.7

1.2

u/l

50.1

39.8

0.23

103

694

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

255

1.85

3.88

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

255

1.85

3.88

1.5

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

505

1.59

3.85

1.3

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

301

1.77

3.79

1.6

1.3

u/l

37.1

33.8

0.25

244

(3026389) Candida sp identified in Specimen by Organism specific culture

564

1.55

3.75

1.4

—

(3023419) Bacteria identified in Sputum by Culture

613

1.53

3.72

2.8

2.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

275

1.79

3.65

2.4

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

497

1.58

3.63

1.2

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

110

2.28

3.61

1.6

1.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

104

707

1.48

3.61

1.3

—

(4306422)

491

1.58

3.58

1.2

—

(3045414) Leukocytes [Presence] in Urine

252

1981

1.29

3.58

2.1

2.0

—

(40768806) Pleura Pathology biopsy report

563

1.54

3.57

1.7

1.6

—

(3045424) Erythrocytes [Presence] in Urine

108

743

1.46

3.53

1.5

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

589

1.52

3.52

1.6

1.3

nmol/l

10.4

0.7

0.49

565

(3036071) Salmonella sp Ab [Titer] in Serum

105

2.29

3.51

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

510

1.56

3.49

1.3

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

303

2447

1.25

3.46

3.2

2.9

e6/l

0.2

0.3

1.84

295

2400

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

139

2.09

3.42

5.7

6.3

66.9

71.3

0.46

110

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

482

1.56

3.39

1.2

1.1

119.9

115.7

0.50

422

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

202

1.89

3.38

1.2

1.1

iu/ml

4.7

12.3

2.48

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

344

1.66

3.32

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.62

3.30

16.6

13.2

mmol/l

4.7

5.5

0.92

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

664

1.47

3.28

1.1

1.2

—

(3023410) Appearance of Cerebral spinal fluid

369

1.63

3.26

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

642

1.47

3.22

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

115

817

1.42

3.21

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

406

3411

1.21

3.20

4.3

3.9

0.5

0.6

0.68

107

800

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

250

1.77

3.19

2.5

2.0

e6/l

618.2

457.6

0.35

212

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

130

2.08

3.17

1.1

1.2

—

(44813793)

229

1.80

3.15

1.1

1.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

143

1058

1.36

3.14

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

597

1.48

3.13

1.6

1.3

nmol/l

0.3

—

(1002224) Polysomnography panel

161

1214

1.34

3.13

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

147

1094

1.35

3.12

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

297

1.69

3.11

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

533

1.51

3.11

1.2

1.3

pmol/l

266.5

268.1

0.02

407

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

545

1.49

3.01

1.6

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

182

1.87

3.00

9.9

5.2

mg/l

59.6

66.0

0.35

128

(4268621)

357

1.60

2.92

2.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

657

1.44

2.90

1.5

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

162

1238

1.32

2.90

6.2

4.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

108

2.13

2.90

1.3

1.1

pmol/l

278.5

289.7

0.07

(3039162) Centromere protein B Ab [Units/volume] in Serum

469

1.52

2.89

1.2

u/ml

47.1

44.9

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

163

1.91

2.89

1.3

1.4

umol/l

28.4

29.6

0.25

158

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

274

1.69

2.86

1.7

1.6

u/l

4.4

6.6

0.47

128

(3010144) Erythrocytes [#/volume] in Synovial fluid

455

1.52

2.84

1.3

e6/l

286277.8

110706.7

0.78

312

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

644

1.44

2.82

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

306

1.64

2.82

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

101

720

1.41

2.81

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

253

1.71

2.80

2.2

1.5

g/l

1.0

0.9

0.87

253

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

238

1.73

2.80

2.6

2.0

e9/l

0.3

0.2

0.56

211

(3023487) Leukocytes [#/volume] in Peritoneal fluid

165

1.88

2.80

2.0

2.2

e6/l

1412.8

5393.3

0.41

117

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1235

11368

1.12

2.78

1.7

1.6

mmol/l

1.4

1.3

2.15

1076

9411

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

110

2.10

2.78

1.3

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.17

2.76

1.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

316

1.62

2.75

2.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

371

1.57

2.74

1.9

2.0

u/field

1.9

1.8

0.03

140

(3001019) Free T4 and TSH panel - Serum or Plasma

151

1155

1.32

2.71

1.8

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

160

1.88

2.70

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

272

1.66

2.67

1.1

—

(3028433) Virus identified in Specimen by Culture

147

1.91

2.64

1.3

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

205

1.76

2.64

1.9

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

337

1.58

2.59

4.0

5.0

u/ml

47.1

54.1

0.14

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.90

2.58

1.1

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

640

1.41

2.57

1.6

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

354

1.56

2.55

1.1

u/ml

3.7

0.01

161

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

229

1862

1.24

2.54

2.0

1.8

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.42

2.53

1.1

1.2

nmol/l

11.4

158006.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

261

1.65

2.53

2.1

ug/min

108.8

220.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

108

2.04

2.51

1.0

1.1

u/ml

4.1

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

342

1.56

2.45

1.1

u/ml

0.9

1.2

0.13

133

(3015183) Erythrocyte sedimentation rate

123

1.96

2.44

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

327

1.57

2.42

1.1

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

117

879

1.34

2.41

1.9

1.7

iu/l

5.8

4.7

0.30

287

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

416

1.50

2.41

1.1

u/ml

3.1

1.6

0.30

157

(44816559) Phosphatidylethanol [Mass/volume] in Blood

598

1.41

2.40

1.6

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

550

1.42

2.36

1.6

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.61

2.35

1.2

ug/l

59.3

132.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.50

2.35

4.9

4.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.15

2.34

2.0

1.1

mmol/l

0.3

2.1

1.49

(3014891) Appearance of Pleural fluid

2.26

2.34

1.3

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.09

2.32

1.6

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

268

1.61

2.31

1.6

1.5

nmol/l

0.3

0.2

0.39

197

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

519

1.43

2.31

1.6

1.3

nmol/l

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

103

765

1.35

2.30

3.4

3.2

—

(3020393) Adenovirus Ag [Presence] in Stool

2.86

2.30

1.1

1.0

—

(3025315) Body weight

2.86

2.30

6.9

4.7

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

372

1.51

2.29

1.3

1.2

95.9

95.2

0.07

345

(4024509)

487

1.44

2.28

1.7

1.6

—

(4146454)

554

1.41

2.28

2.8

—

(3048879) Bone marrow aspiration report

148

1.83

2.28

1.4

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

185

1.73

2.27

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

326

1.54

2.23

1.0

—

(3045142) Bone marrow Pathology biopsy report

557

1.41

2.22

1.4

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

179

1.74

2.22

1.1

1.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.34

2.21

1.1

1.2

85.4

78.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

217

1.66

2.21

1.0

1.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

5.56

2.21

4.6

6.0

e6/l

84.6

50.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

303

1.56

2.21

1.1

1.0

u/ml

2.9

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.05

2.21

1.0

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

157

1.79

2.21

1.5

2.1

u/ml

2840.0

21945.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

225

1.65

2.20

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

121

1.91

2.20

1.5

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

210

1.67

2.19

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

304

1.55

2.18

2.9

2.1

42.0

40.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

243

1.61

2.12

2.7

2.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

123

1.87

2.11

1.4

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.05

2.11

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.71

2.10

2.0

1.8

—

(3003181) Sodium [Moles/volume] in Urine

112

856

1.32

2.10

1.3

mmol/l

65.6

62.3

0.38

700

(3041918) Cholesterol [Moles/volume] in Pleural fluid

102

1.96

2.10

1.9

1.1

mmol/l

1.3

1.7

0.73

(3011412) CD3 cells [#/volume] in Blood

373

1.48

2.07

2.8

2.1

e9/l

1.0

1.1

0.14

226

(3025018) Bordetella pertussis Ab [Titer] in Serum

183

1.70

2.07

1.5

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

214

1.64

2.06

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

374

1.48

2.05

1.0

1.1

—

19.6

—

(3029075) Extractable nuclear Ab panel - Serum

103

1.95

2.05

1.1

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.32

2.04

2.5

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

246

1.59

2.03

1.6

1.3

u/ml

1.1

1.4

0.11

128

(3000060) B lymphocytes [#/volume] in Blood

2.11

2.02

2.3

1.9

e6/l

154.4

134.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

240

2015

1.20

2.01

2.1

1.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

140

1.79

2.00

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

155

1.75

1.99

1.2

g/l

39.2

39.7

0.06

(3016018) Differential panel - Cerebral spinal fluid

402

1.45

1.97

1.2

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

108

830

1.31

1.96

2.0

1.6

nmol/l

0.9

0.8

0.78

688

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

119

1.85

1.96

3.0

2.0

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

3.34

1.96

1.3

1.4

pmol/l

20.2

28.6

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

164

1.71

1.94

2.4

1.8

ug/l

41.7

53.7

1.22

158

(3008757) Leukocyte morphology finding [Identifier] in Blood

530

1.38

1.93

3.5

4.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

226

1.60

1.93

3.0

2.6

39.5

37.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.12

1.92

1.3

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

203

1.63

1.91

1.6

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

456

1.41

1.89

1.2

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.31

1.87

1.3

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.03

1.85

1.0

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

309

1.49

1.85

1.0

mg/l

290.3

285.2

0.22

273

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.17

1.82

1.2

1.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

640

1.33

1.81

1.8

2.0

ug/l

22.2

25.0

0.25

626

(40757373) Influenza virus identified in Isolate

1.92

1.79

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

135

1082

1.25

1.79

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.96

1.79

1.1

—

(3044941) Cell count panel - Synovial fluid

737

1.31

1.79

1.5

1.4

—

(3044007) Cell count panel - Peritoneal fluid

131

1.76

1.77

2.3

2.1

—

(3033799) Differential panel - Peritoneal fluid

146

1.72

1.77

1.2

2.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.44

1.75

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.03

1.74

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.85

1.71

1.4

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

194

1.60

1.71

1.2

1.5

umol/l

11.8

12.7

0.07

123

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.18

1.67

1.2

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

149

1.68

1.66

1.8

2.0

e6/l

2461.7

20260.9

0.83

(3041096) Erythrocytes [Presence] in Urine by Automated

1116

10467

1.09

1.65

4.4

3.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

123

987

1.25

1.64

1.3

1.2

mg/l

783.6

551.3

0.52

115

927

(3044290) Cell count panel - Cerebral spinal fluid

776

1.28

1.61

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

166

1.63

1.61

1.6

1.3

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.50

1.59

1.0

1.1

—

3.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

206

1.56

1.59

1.1

1.0

u/ml

0.1

0.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.00

1.58

1.5

1.4

—

(4015189)

144

1.67

1.57

1.8

2.2

—

(40761536) Microorganisms panel - Urine sediment

307

3490

0.87

1.56

5.4

4.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

240

1.50

1.54

1.1

u/ml

1.8

2.2

0.10

(3008898) HLA-B27 [Presence]

119

961

1.24

1.53

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

100

1.80

1.52

1.0

u/ml

7.2

0.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.59

1.51

2.9

3.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.07

1.49

2.3

2.2

—

(3034426) Prothrombin time (PT)

116

1.73

1.48

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.44

1.47

1.0

1.1

—

(3004775) Volume in Urine collected for unspecified duration

393

1.38

1.47

2.2

647.2

640.5

0.04

245

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.22

1.46

2.7

1.4

—

(3011648) Oxygen content in Venous blood

360

1.39

1.46

2.0

1.9

11.1

10.8

0.22

360

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.04

1.43

2.3

2.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

253

1.47

1.42

1.1

u/ml

1.6

2.0

0.16

102

(3019832) Treponema pallidum Ab [Presence] in Serum

162

1364

1.19

1.40

1.5

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.18

1.39

2.5

2.4

u/field

0.4

0.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

173

1.56

1.39

1.5

1.7

nmol/l

3.2

7.7

0.83

147

(3009871) Measles virus Ab [Titer] in Serum

1.80

1.37

1.6

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

425

1.35

1.36

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

300

1.40

1.31

2.6

2.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

185

1.52

1.28

1.3

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

218

1898

1.16

1.28

1.3

—

(40768800) Prostate Pathology biopsy report

134

1120

1.20

1.28

1.2

—

(3011544) Albumin [Mass/volume] in Pleural fluid

2.09

1.27

1.0

1.1

g/l

12.3

17.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.09

1.27

1.1

1.5

—

(3042631) Mycobacterium sp identified in Specimen

695

1.26

1.27

2.6

2.9

—

(3000330) Specific gravity of Urine by Test strip

271

2398

1.14

1.27

5.4

3.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

244

1.44

1.25

5.1

6.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

106

870

1.22

1.23

1.2

mmol/l

3.6

3.9

1.42

812

(3047007) Chlamydophila sp Ab [Presence] in Serum

442

1.32

1.22

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

197

1.47

1.19

1.2

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.31

1.18

2.8

1.7

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

622

1.26

1.18

2.3

32.8

0.05

616

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

231

1.43

1.17

1.6

1.5

u/l

6.4

6.5

0.02

198

(21494755) Public health laboratory ask at order entry panel

166

1924

0.86

1.17

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

223

1.44

1.16

1.4

1.8

—

9.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

1.16

0.0

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

102

1.67

1.16

11.2

7.7

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.50

1.15

11.0

5.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

196

2240

0.87

1.14

1.9

1.8

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

118

1.61

1.14

10.5

7.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

111

1.62

1.12

2.4

2.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.96

1.11

1.6

1.4

umol/l

56.8

41.5

—

(3002619) Bacteria identified in Specimen by Culture

1.78

1.10

1.3

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

2.19

1.08

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

108

903

1.20

1.07

1.4

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

162

1.48

1.04

1.1

ng/l

1029.0

397.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.27

1.03

1.2

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.92

1.02

1.3

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.92

1.02

2.1

1.8

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

188

1.44

1.01

1.3

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

564

1.24

1.00

1.4

1.5

65.0

61.1

0.41

356

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

147

1.50

1.00

1.5

1.2

ug/l

196.3

513.7

0.51

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.00

1.00

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

115

1.57

0.99

2.1

1.4

ug/l

8.6

9.3

0.46

115

(3006184) Hemoglobin [Mass/volume] in Capillary blood

128

1096

1.17

0.99

2.2

g/l

124.2

127.9

0.66

780

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

189

1.43

0.98

1.1

u/l

1.1

0.13

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.84

0.98

1.1

1.2

mg/l

10.9

7.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.18

0.98

1.0

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.18

0.98

1.6

1.0

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

2.18

0.98

2.0

mg/l

1.5

1.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.85

0.96

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

113

961

1.18

0.95

1.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

364

1.29

0.94

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

364

1.29

0.94

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.61

0.93

1.1

81.0

84.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

277

1.34

0.93

2.7

2.1

15.4

14.5

0.16

111

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

167

1.44

0.91

1.3

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

230

0.65

0.88

1.1

—

(4281824)

448

1.25

0.88

1.1

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.58

0.87

1.1

1.3

85.0

82.2

—

(3000034) Microalbumin [Mass/volume] in Urine

431

1.26

0.87

4.4

3.2

mg/l

45.1

32.4

0.34

330

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.00

0.87

1.0

—

(3017569) Oxygen content in Arterial blood

246

1.34

0.87

2.8

2.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

273

1.32

0.85

2.7

2.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

298

0.70

0.84

1.2

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.76

0.83

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.61

0.81

8.5

7.6

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

189

0.63

0.81

1.3

1.2

—

64.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

130

1.46

0.80

1.1

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.82

0.79

1.0

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

125

1426

0.87

0.78

1.4

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

842

1.17

0.77

1.3

e6/l

16.8

25.8

0.38

646

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

123

1.47

0.77

1.1

miu/ml

1254.1

1657.4

1.15

123

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

843

1.17

0.77

1.4

e6/l

519.8

949.3

0.75

687

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

243

1.32

0.77

3.0

3.3

—

(3006653) Thiamine [Moles/volume] in Blood

209

1.34

0.75

1.1

1.2

nmol/l

134.0

139.2

0.18

209

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.57

0.74

1.4

1.6

ng/l

93.5

144.1

1.39

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.67

0.74

1.0

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

150

1.40

0.73

3.0

2.9

umol/l

26.7

29.8

0.77

110

(3028679) Herpes simplex virus Ab [Presence] in Serum

150

1.40

0.73

1.3

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

125

1.44

0.72

1.2

1.5

iu/ml

—

1410525.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

107

0.56

0.72

1.5

2.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

507

1.21

0.71

3.4

3.5

58.8

58.5

0.03

315

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

326

1.26

0.71

1.4

1.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.92

0.70

1.0

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

170

0.65

0.70

3.9

3.8

53.1

54.7

0.09

163

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

126

1.43

0.70

1.4

1.6

ug/l

0.4

0.35

(3008536) Aspergillus sp Ab [Presence] in Serum

1.53

0.68

1.4

1.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.67

0.68

1.1

1.0

—

(3024263) Appearance of Synovial fluid

257

1.29

0.68

1.9

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.60

0.68

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.79

0.66

1.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.79

0.66

2.0

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.59

0.65

1.7

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.72

0.64

1.4

1.0

—

(4034850)

123

1380

0.89

0.63

13.3

11.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.60

0.0

1.3

—

(40758358) Immune stain study

0.00

0.60

0.0

1.0

—

(4212803)

1.48

0.57

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

273

0.77

0.54

2.4

1.6

—

68.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

125

0.64

0.54

1.3

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.58

0.54

1.2

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

610

1.15

0.52

1.1

1.3

miu/ml

220.4

202.3

0.11

236

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.61

0.52

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.61

0.52

1.0

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.45

0.51

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

215

1.26

0.50

1.2

1.4

pmol/l

120.5

192.1

—

(40762365) Oxygen content in Arterial blood by calculation

1.41

0.50

3.0

ml/dl

14.9

14.8

0.03

(3023323) Follitropin [Units/volume] in Serum or Plasma

773

1.13

0.49

1.3

iu/l

35.7

34.0

0.15

660

(3010421) pH of Blood

135

1230

1.10

0.49

5.1

4.5

7.4

0.11

108

1035

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.52

0.48

4.6

4.7

—

(4133840)

1.41

0.46

1.3

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

209

1.25

0.46

1.3

1.5

—

(3018572) Chloride [Moles/volume] in Blood

121

1102

1.10

0.46

7.1

mmol/l

105.1

0.01

111

989

(3039000) Anion gap in Blood

121

1102

1.10

0.46

7.1

mmol/l

11.1

11.2

0.18

111

989

(3043410) Blood group antigens tested for on Red Blood Cells

120

1.33

0.46

1.6

2.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.43

0.46

5.4

2.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

524

1.15

0.45

1.6

—

(3037556) Urate [Mass/volume] in Serum or Plasma

147

1.29

0.45

1.3

1.5

—

(40765096) Chromosome analysis panel by Banding

156

1.28

0.45

1.3

1.1

—

(4027681)

183

1.26

0.44

1.1

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.40

0.44

1.8

1.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

441

1.16

0.44

1.2

mmol/l

8.1

7.7

0.42

324

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

501

4807

1.05

0.44

4.0

3.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

275

1.20

0.43

1.1

1.2

mmol/l

11.2

11.7

0.17

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

184

1.25

0.43

1.5

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

184

1.25

0.43

1.5

1.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

113

1.33

0.42

1.0

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.36

0.41

1.2

2.1

ug/l

2.7

2.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

0.00

0.41

0.0

1.2

—

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.36

0.41

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.47

0.40

1.4

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

186

1.24

0.40

1.6

1.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.31

0.39

1.4

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.43

0.39

1.0

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.43

0.39

1.0

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.38

0.38

1.5

1.6

—

(3027008) Opiates [Presence] in Urine

457

1.14

0.38

1.2

1.7

—

(1616796) Gas panel - Central venous blood

115

1058

1.09

0.38

4.5

3.8

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

234

1.20

0.37

1.4

1.3

nmol/l

1.1

1.2

0.08

175

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

383

1.15

0.37

1.8

1.6

—

1221.8

—

(3027944) Amphetamines [Presence] in Urine

449

1.14

0.37

1.2

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

116

1.29

0.37

1.0

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

535

1.12

0.36

4.5

4.7

umol/l

374.0

349.3

0.65

462

(44806071)

1.43

0.35

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.40

0.35

1.7

2.0

umol/l

13.0

19.1

—

(3028300) Cannabinoids [Presence] in Urine

461

1.13

0.34

1.2

1.7

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.36

0.34

1.7

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

834

1.09

0.34

4.5

3.7

60.7

58.2

1.15

834

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.32

0.33

1.2

—

(3011288) Drugs identified in Urine by Screen method

293

1.16

0.33

1.2

2.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

109

1.29

0.33

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.30

0.33

1.0

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

0.68

0.33

3.7

6.8

—

(3035933) Granulocytes/100 leukocytes in Blood

1.35

0.32

1.1

1.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.31

0.31

2.2

3.4

—

(3000764) Benzodiazepines [Presence] in Urine

457

1.12

0.30

1.2

1.7

—

(3045716) Anion gap in Serum or Plasma

231

1.17

0.29

2.1

2.2

mmol/l

8.6

9.3

0.45

180

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

250

1.16

0.29

1.2

1.1

nmol/l

1.3

13.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

440

1.11

0.28

1.5

22.3

29.1

0.84

273

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.29

0.28

1.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.25

0.27

1.0

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

233

1.16

0.27

1.1

u/l

24.4

34.6

0.82

172

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

233

1.16

0.27

1.1

u/l

84.5

93.0

0.30

175

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

394

1.12

0.27

1.3

1.4

—

(3014271) Vancomycin [Susceptibility]

290

1.14

0.27

3.0

—

(3000285) Sodium [Moles/volume] in Blood

1.21

0.26

1.1

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

321

0.87

0.26

1.1

1.2

—

(44806420)

150

1.20

0.26

2.5

2.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

132

1247

1.06

0.25

3.5

3.2

mmol/l

24.5

25.0

0.75

121

1085

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

235

1.15

0.25

1.4

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

235

1.15

0.25

1.4

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

235

1.15

0.25

1.4

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

235

1.15

0.25

1.4

1.6

—

(3004451) EKG impression Narrative

254

1.14

0.25

1.2

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

125

0.80

0.23

1.8

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.25

0.22

1.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

373

3837

0.97

0.22

4.2

4.0

mmol/l

1.2

0.53

337

3358

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

343

1.11

0.22

1.0

ng/l

261.4

324.4

1.18

230

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.19

0.21

1.6

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.19

0.21

1.6

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.19

0.21

1.6

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

2.0

—

(3042517) Benzodiazepines panel - Urine

0.00

0.21

0.0

1.5

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

344

1.11

0.21

1.0

ng/l

674.4

689.4

0.08

226

(3022621) pH of Urine by Test strip

301

2920

1.03

0.20

3.8

3.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.25

0.20

1.2

1.9

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

345

1.10

0.20

1.0

ng/l

52.3

45.0

0.18

229

(3044242) Glucose [Moles/volume] in Arterial blood

259

1.12

0.20

2.4

1.9

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

113

0.80

0.20

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

113

0.80

0.20

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

113

0.80

0.20

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

113

0.80

0.20

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

102

1075

0.95

0.19

1.6

1.7

mg/l

3.3

3.5

0.08

767

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

122

0.82

0.19

1.0

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

118

1.19

0.19

1.1

1.3

nmol/l

151.4

124.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

822

1.06

0.19

3.4

3.6

0.9

1.6

1.49

624

(3016879) Cocaine [Presence] in Urine

424

1.09

0.18

1.2

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

121

0.83

0.18

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.15

0.17

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.13

0.17

1.4

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

108

1031

1.05

0.17

2.6

15.2

16.0

1.20

536

(3025577) Chromium [Mass/volume] in Blood

340

0.91

0.16

1.7

2.1

ug/l

1.9

2.2

0.64

288

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

162

0.86

0.16

1.3

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

273

1.10

0.16

1.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.78

0.15

1.0

1.1

—

(3012501) Base excess in Blood by calculation

110

1054

1.04

0.15

5.5

4.7

mmol/l

2.9

2.7

0.25

730

(3040151) Glucose [Moles/volume] in Capillary blood

534

0.94

0.15

1.6

20.7

mmol/l

7.7

7.5

0.20

445

(3019977) pH of Arterial blood

274

1.10

0.15

3.0

2.5

7.4

0.01

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

113

1.15

0.13

1.4

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

110

0.82

0.13

1.0

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

396

0.93

0.12

1.4

1.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

148

0.88

0.12

1.1

—

9.1

—

(3028707) Methadone [Presence] in Urine by Screen method

210

1.10

0.12

1.0

1.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

288

1.08

0.11

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

168

0.89

0.11

1.3

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

602

1.05

0.11

1.0

1.1

iu/ml

5.4

60.2

—

123

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

289

1.07

0.11

1.5

—

(3020650) Glucose [Presence] in Urine

1.15

0.10

1.1

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

516

1.05

0.09

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.09

0.09

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.15

0.09

2.2

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.04

0.09

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

217

0.92

0.09

1.4

1.5

1.3

4.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.13

0.09

1.7

1.4

—

(3016038) Potassium [Moles/volume] in Urine

321

1.06

0.09

1.2

1.1

mmol/l

29.8

34.8

0.58

277

(3047181) Lactate [Moles/volume] in Blood

154

1507

1.02

0.08

6.9

6.3

mmol/l

1.2

1.3

0.53

141

1338

(4198724)

1.03

0.07

1.0

1.4

—

(3008295) Osmolality of Serum or Plasma

466

0.97

0.05

1.3

mosm/kgh2o

280.6

276.7

0.52

357

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

139

1.08

0.05

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

139

1.08

0.05

2.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

159

1.07

0.05

3.5

2.1

—

(40768793) Breast Pathology biopsy report

907

0.98

0.04

1.2

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

1.10

0.04

1.2

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

698

1.02

0.03

1.8

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

350

0.97

0.03

1.3

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

152

1.05

0.02

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

104

1050

0.99

0.01

2.6

2.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

117

0.94

0.01

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

117

0.94

0.01

1.5

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

117

0.94

0.01

1.0

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

762

1.01

0.01

1.9

mmol/l

1.9

1.7

1.48

739

(3021901) Oxygen saturation in Capillary blood

912

1.01

0.01

3.2

2.9

—

(40768795) Lymph node Pathology biopsy report

437

0.98

0.01

1.3

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.06

0.01

1.2

—

(3005033) Fetal Nuchal fold Thickness US

116

0.95

0.00

1.5

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

286

0.98

0.00

1.1

1.4

promille

1.5

1.1

0.63

217

(1617658) Protocol used for examination of sentinel lymph nodes

306

0.98

0.00

1.0

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

444

1.01

0.00

3.4

3.6

u/ml

94.3

41.3

0.58

439

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

265

1.02

0.00

3.0

3.9

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

144

0.97

0.00

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

144

0.97

0.00

1.5

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

103

0.97

0.00

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

143

0.98

0.00

1.5

1.4

—

(3000012) Reticulocyte production index

266

1.02

0.00

1.2

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

143

0.98

0.00

1.5

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

317

1.01

0.00

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

119

1.01

0.00

1.4

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

141

0.99

0.00

3.5

2.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

151

0.99

0.00

1.7

2.1

umol/l

33.0

133.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

106

1061

1.00

0.00

3.2

2.9

kpa

7.9

0.24

101

980

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.94

0.00

1.0

1.2

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(4038314)

0.00

0.0

1.3

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.02

0.00

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.3

—

2531.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

2.1

—

2.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.95

0.00

1.0

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.91

0.00

1.0

1.2

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_ASCENDING_COLON and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_ASCENDING_COLON	1.233 [1.11, 1.37]	< 0.001
Birth year	0.997 [0.99, 1.01]	0.442

During the follow-up period (1.1.1998 — 31.12.2019), 1729 out of 8719 females with CD2_BENIGN_ASCENDING_COLON died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_ASCENDING_COLON	1.253 [1.12, 1.41]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.017

During the follow-up period (1.1.1998 — 31.12.2019), 2517 out of 8927 males with CD2_BENIGN_ASCENDING_COLON died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_ASCENDING_COLON.

N-year risk	Females	Males
1	0.115%	0.22%
5	0.608%	1.527%
10	1.8%	4.065%
15	3.526%	7.633%
20	6.387%	12.44%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_ASCENDING_COLON – Benign neoplasm: Ascending colon

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Ascending colon

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints